NCT05504941Recruiting
Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage
Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage - an EXPLOrative Pilot Study (HemEXPLO)
Source: ClinicalTrials.gov · Last updated 11 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is to determine if a treatment target for a potential endovascular therapy exists in patients with an acute, spontaneous (non-traumatic) ICH.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 15 Aug 2022
- Start date
- 25 Oct 2022
- Primary completion date
- Dec 2026
- Lead sponsor
- University Hospital, Basel, Switzerland
- Diseases
- Stroke
- NCT number
- NCT05504941
What you commit to
- Study type: Interventional
- Planned participants: 15
- From 25 Oct 2022 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Any time critical surgical or minimal invasive intervention is planned
Other illness
- High probability that the etiology of the bleeding is a ruptured aneurysm, an arteriovenous malformation or an amyloid angiopathy as judged by the treating physician
- Known severe kidney insufficiency (Glomerular filtration rate \< 30 ml/min)
Other
- Evidence of an ongoing pregnancy, a negative pregnancy test is mandatory in all persons of childbearing potential
- Contraindications against the use of iodine contrast media
Who the study is looking for
- Diagnosis of an acute spontaneous ICH based on non-contrast CT
- Time from symptom onset to anticipated start of cerebral DSA of under 3 hours
- Agreement of the treating physician to perform DSA
- Informed consent documented by signature or fulfilling the criteria for emergency consent procedures (deferral of consent)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Neuroradiology, University Hospital Basel Coordinator of this site? Confirm its status | Basel | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.